Clinical Trial Update: Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients

View source ↗

Summary

A completed post-marketing surveillance study evaluated the safety and efficacy of duloxetine (Cymbalta) for diabetic peripheral neuropathic pain in Filipino pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pain | Status: COMPLETED